生物标志物 生物标志物
Claudia Aponte1,2, Laura García3,4, María José Hidalgo Ramírez5,6
1Grupo Neuropsicología y Conducta, Universidad de Antioquia, Medellín, Antioquia, Colombia.
Alzheimer's & dementia : the journal of the Alzheimer's Association
|December 26, 2025
概括
图表指标显示,PSEN1 E280A突变的无症状载体中大脑连接性发生变化. 在非携带者中,中间中心性更高,这表明在阿尔茨海默氏症早期阶段的局部网络差异.
科学领域:
- 神经成像是一种神经成像.
- 网络神经科学 网络神经科学
- 阿尔茨海默氏症疾病研究研究
背景情况:
- 图表指标分析了阿尔茨海默病 (AD) 的功能连接.
- 与对照组相比,AD和MCI患者的节点和全球图表指标不同.
- 自体主导性阿尔茨海默病 (ADAD) 突变携带者可能在疾病阶段表现出不同的图表指标.
研究的目的:
- 在默认模式网络 (DMN) 中调查图形度量特征.
- 专门检查PSEN1 E280A突变的无症状携带者.
主要方法:
- 从32个无症状载体 (aC) 和25个非载体对照 (nC) 获得的rs-fMRI数据.
- 使用CONN工具箱进行预处理的数据;使用Schaefer地图 (79ROI) 提取的DMN和休息状态网络 (RSN).
- 使用GRETNA工具箱在稀疏度值 (0.05-0.5) 上计算的图表指标;统计分析包括Wilcoxon测试和带Bonferroni校正的线性混合模型 (LMM).
主要成果:
- 学历在各组之间有显著差异 (p < 0.001),但年龄和性别没有.
- 在nC中,中间中心性 (Bc) 比aC更高 (p=0.0051).
- 线性混合模型显示了节点图度量交叉点的群体差异,聚类系数,中间中心性,局部效率和中心度度倾斜在aC和nC之间有所不同.
结论:
- 间隔中心性区分无症状携带者 (aC) 和非携带者 (nC),在nC中较高.
- 这表明局部网络组织,其中节点在nC中更为中心,可能反映了aC的早期病理生理变化.
- 观察到的aC局部变化可能代表DMN重组,以保持认知功能,尽管潜在的AD相关变化.
相关概念视频
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
749
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
749
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
516
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
516


